Coherus Oncology Ownership | Who Owns Coherus Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Coherus Oncology Ownership Summary


Coherus Oncology is owned by 27.46% institutional investors, 12.44% insiders, and 60.11% retail investors. Blackrock is the largest institutional shareholder, holding 10.42% of CHRS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Coherus Oncology shares.

CHRS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCoherus Oncology27.46%12.44%60.11%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock11.75M10.42%$20.33M
Blackrock funding, inc. /de10.46M9.01%$17.15M
Vanguard group10.32M8.89%$16.93M
Tang capital management5.10M4.39%$8.36M
Kohlberg kravis roberts3.04M2.62%$4.93M
Geode capital management2.74M2.36%$4.50M
State street2.22M1.92%$3.65M
Cm management2.10M1.81%$3.44B
C worldwide group1.93M1.66%$3.16M
Panagora asset management1.38M1.19%$2.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management2.10M2.87%$3.44B
Tang capital management5.10M0.32%$8.36M
Kohlberg kravis roberts3.04M0.08%$4.93M
Tyche wealth partners195.87K0.06%$321.22K
C worldwide group1.93M0.05%$3.16M
Wealth group52.20K0.05%$72.00K
State of wyoming119.27K0.02%$164.59K
Providence wealth advisors15.00K0.02%$26.10K
Carr financial group35.20K0.02%$57.72K
Panagora asset management1.38M0.01%$2.26M

Top Buyers

HolderShares% AssetsChange
Jacobs levy equity management1.00M0.01%1.00M
Panagora asset management1.38M0.01%581.64K
Blackrock11.75M0.00%521.98K
Norges bank491.50K0.00%491.50K
Millennium management1.05M0.00%252.09K

Top Sellers

HolderShares% AssetsChange
Temasek (private)---5.82M
Point72 asset management---5.28M
Bank of america corp /de/275.10K--2.15M
Lazard asset management---883.73K
Rubric capital management lp---867.80K

New Positions

HolderShares% AssetsChangeValue
Norges bank491.50K0.00%491.50K$850.29K
Metlife investment management63.68K0.00%63.68K$104.43K
O'shaughnessy asset management63.16K0.00%63.16K$103.58K
Two sigma investments, lp35.71K0.00%35.71K$58.57K
Quadrature capital18.17K0.00%18.17K$29.71K

Sold Out

HolderChange
Eagle bay advisors-30.00
Nelson, van denburg & campbell wealth management group-31.00
Farther finance advisors-47.00
Cornerstone planning group-49.00
Larson financial group-79.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202558-48.67%31,871,888-42.43%271.21%22-51.11%21-41.67%
Jun 30, 2025113-4.24%55,361,532-10.83%471.66%46-6.12%35-
Mar 31, 2025117-7.14%61,758,313-5.38%531.66%50-18.03%346.25%
Dec 31, 202475-42.75%35,423,873-53.96%300.69%37-35.09%18-47.06%
Sep 30, 2024131-5.07%76,943,748-5.87%661.32%57-20.83%34-2.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.64M3.13%-80.18K
Vanguard US Total Market Shares ETF3.43M2.96%-
iShares Russell 2000 ETF2.58M2.22%-
C WorldWide Healthcare Select 1A1.93M1.66%-
Vanguard Strategic Equity Inv1.58M1.37%-121.48K
Vanguard Explorer Inv1.57M1.36%-120.61K
Vanguard Institutional Extnd Mkt Idx Tr1.32M1.13%-600.99K
Fidelity Small Cap Index1.08M0.93%-73.15K
AlphaCentric LifeSci Healthcare I1.00M0.87%-
BlackRock Advantage Small Cap Core Instl1.00M0.86%-

Recent Insider Transactions


DateNameRoleActivityValue
May 23, 2025Wahlstrom Mats-Sell$73.88K
Nov 22, 2023Lanfear Dennis M President & CEOSell$449.77K
Oct 15, 2021Stilwell McDavid Chief Financial OfficerSell$58.92K
Sep 28, 2021HEALY JAMES-Sell$829.81K
Sep 27, 2021HEALY JAMES-Sell$1.81M

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

CHRS Ownership FAQ


Who Owns Coherus Oncology?

Coherus Oncology shareholders are primarily institutional investors at 27.46%, followed by 12.44% insiders and 60.10% retail investors. The average institutional ownership in Coherus Oncology's industry, Biotech Stocks , is 45.22%, which Coherus Oncology falls below.

Who owns the most shares of Coherus Oncology?

Coherus Oncology’s largest shareholders are Blackrock (11.75M shares, 10.42%), Blackrock funding, inc. /de (10.46M shares, 9.01%), and Vanguard group (10.32M shares, 8.89%). Together, they hold 28.33% of Coherus Oncology’s total shares outstanding.

Does Blackrock own Coherus Oncology?

Yes, BlackRock owns 10.42% of Coherus Oncology, totaling 11.75M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 20.33M$. In the last quarter, BlackRock increased its holdings by 521.98K shares, a 4.65% change.

Who is Coherus Oncology’s biggest shareholder by percentage of total assets invested?

Cm management is Coherus Oncology’s biggest shareholder by percentage of total assets invested, with 2.87% of its assets in 2.1M Coherus Oncology shares, valued at 3.44B$.

Who is the top mutual fund holder of Coherus Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Coherus Oncology shares, with 3.13% of its total shares outstanding invested in 3.64M Coherus Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools